Bausch & Lomb (BLCO) Cash & Equivalents (2021 - 2026)

Bausch & Lomb's Cash & Equivalents history runs 6 years deep, the most recent figure standing at $268.0 million for Q1 2026.

• Quarterly Cash & Equivalents rose 32.67% year-over-year to $268.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $268.0 million (up 32.67% YoY) and the FY2025 annual result came in at $383.0 million, up 25.57% from the prior year.
• Cash & Equivalents was $268.0 million for Q1 2026 at Bausch & Lomb, down from $383.0 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $437.0 million in Q2 2022 and bottomed at $190.0 million in Q1 2022.
• A 5-year average of $314.5 million and a median of $315.0 million in 2024 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents soared 103.45% — and 2025, when it slumped 35.87%.
• Bausch & Lomb's Cash & Equivalents stood at $354.0 million in 2022, then declined by 6.5% to $331.0 million in 2023, then retreated by 7.85% to $305.0 million in 2024, then gained by 25.57% to $383.0 million in 2025, then sank by 30.03% to $268.0 million in 2026.
• Business Quant data shows BLCO's Cash & Equivalents at $268.0 million in Q1 2026, $383.0 million in Q4 2025, and $310.0 million in Q3 2025.